{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T02:54:36Z","timestamp":1794711276309,"version":"4.9.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:00:00Z","timestamp":1687305600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ymgmr.2023.100988","type":"journal-article","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T05:45:58Z","timestamp":1688017558000},"page":"100988","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Long-term administration of intravenous Trappsol\u00ae Cyclo\u2122 (HP-\u03b2-CD) results in clinical benefits and stabilization or slowing of disease progression in patients with Niemann-Pick disease type C1: Results of an international 48-week Phase I\/II trial"],"prefix":"10.1016","volume":"36","author":[{"given":"Reena","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Hastings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orna","family":"Staretz-Chacham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Raiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Paucar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronen","family":"Spiegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Hurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benny","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Kjems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Hrynkow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgmr.2023.100988_bb0005","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13023-018-0785-7","article-title":"Consensus clinical management guidelines for Niemann-Pick disease type C","volume":"13","author":"Geberhiwot","year":"2018","journal-title":"Orphanet. J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/gim.2015.25","article-title":"High incidence of unrecognized visceral\/neurological late-onset Niemann-pick disease, type C1, predicted by analysis of massively parallel sequencing data sets","volume":"18","author":"Wassif","year":"2016","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0015","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1212\/CPJ.0000000000000399","article-title":"Recommendations for the detection and diagnosis of Niemann-pick disease type C: an update","volume":"7","author":"Patterson","year":"2017","journal-title":"Neurol. Clin. Pract."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1172-5-16","article-title":"Niemann-pick disease type C","volume":"5","author":"Vanier","year":"2010","journal-title":"Orphanet. J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0025","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s004399900059","article-title":"NPC1 gene mutations in Japanese patients with Niemann-pick disease type C","volume":"105","author":"Yamamoto","year":"1999","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0030","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1086\/302620","article-title":"Mutations in NPC1 highlight a conserved NPC1-specific cysteine-rich domain","volume":"65","author":"Greer","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0035","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/humu.10255","article-title":"Identification of 58 novel mutations in Niemann-pick disease type C: correlation with biochemical phenotype and importance of PTC1-like domains in NPC1","volume":"22","author":"Park","year":"2003","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0040","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ymgme.2009.06.008","article-title":"Recommendations on the diagnosis and management of Niemann-Pick disease type C","volume":"98","author":"NP-C Guidelines Working Group","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0045","first-page":"1109","article-title":"The complexity of a monogenic neurodegenerative disease: more than two decades of therapeutic driven research into Niemann-pick type C disease","volume":"2019","author":"Hammond","year":"1864","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.ymgmr.2023.100988_bb0050","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jbior.2018.08.001","article-title":"Niemann-pick type C disease: the atypical sphingolipidosis","volume":"70","author":"Newton","year":"2018","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0055","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jnc.14895","article-title":"Niemann-pick type C disease: cellular pathology and pharmacotherapy","volume":"153","author":"Wheeler","year":"2020","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0060","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bbamcr.2008.11.014","article-title":"Secondary lipid accumulation in lysosomal disease","volume":"1793","author":"Walkley","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgmr.2023.100988_bb0065","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/cne.10522","article-title":"Patterned Purkinje cell degeneration in mouse models of Niemann-pick type C disease","volume":"456","author":"Sarna","year":"2003","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006951","article-title":"Chronic cyclodextrin treatment of murine Niemann-pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression","volume":"4","author":"Davidson","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgmr.2023.100988_bb0075","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1212\/01.wnl.0000345040.01917.9d","article-title":"Saccades in adult Niemann-pick disease type C reflect frontal, brainstem, and biochemical deficits","volume":"72","author":"Abel","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.ymgmr.2023.100988_bb0080","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/brain\/awl260","article-title":"The adult form of Niemann-pick disease type C","volume":"130","author":"S\u00e9vin","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.ymgmr.2023.100988_bb0085","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1212\/WNL.0b013e31828869f9","article-title":"Niemann-pick type C is frequent in adult ataxia with cognitive decline and vertical gaze palsy","volume":"80","author":"Schicks","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.ymgmr.2023.100988_bb0090","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/mds.10541","article-title":"Adult-onset Niemann-pick type C disease: a clinical, neuroimaging, and molecular genetic study","volume":"18","author":"Battisti","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0095","doi-asserted-by":"crossref","first-page":"6600","DOI":"10.3390\/ijms22126600","article-title":"Neurodegeneration in Niemann-pick type C disease: an updated review on pharmacological and non-pharmacological approaches to counteract brain and cognitive impairment","volume":"22","author":"Cariati","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0100","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1136\/jnnp.2005.086785","article-title":"Niemann-pick type C disease in a 68-year-old patient","volume":"77","author":"Trendelenburg","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymgmr.2023.100988_bb0105","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(07)70194-1","article-title":"Miglustat for treatment of Niemann-pick C disease: a randomised controlled study","volume":"6","author":"Patterson","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0110","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/jimd.12245","article-title":"Long-term survival outcomes of patients with Niemann-pick disease type C receiving miglustat treatment: a large retrospective observational study","volume":"43","author":"Patterson","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0115","author":"emc"},{"key":"10.1016\/j.ymgmr.2023.100988_bb0120","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s10545-011-9368-7","article-title":"Gastrointestinal disturbances and their management in miglustat-treated patients","volume":"34","author":"Belmatoug","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0125","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1177\/0883073812464526","article-title":"Effects of miglustat on stabilization of neurological disorder in niemann-pick disease type C: Iranian pediatric case series","volume":"28","author":"Karimzadeh","year":"2013","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0130","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.addr.2007.05.012","article-title":"Cyclodextrins as pharmaceutical solubilizers","volume":"59","author":"Brewster","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0135","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1002\/jps.23077","article-title":"Cyclodextrins as functional excipients: methods to enhance complexation efficiency","volume":"101","author":"Loftsson","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0140","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1194\/jlr.M700525-JLR200","article-title":"Genetic variations and treatments that affect the lifespan of the NPC1 mouse","volume":"49","author":"Liu","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0145","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1073\/pnas.0810895106","article-title":"Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1\u2212\/\u2212 mouse","volume":"106","author":"Liu","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0150","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2217\/clp.12.31","article-title":"Therapeutic potential of cyclodextrins in the treatment of Niemann-pick type C disease","volume":"7","author":"Liu","year":"2012","journal-title":"Clin. Lipidol."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0155","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0024-3205(01)01384-4","article-title":"Cyclodextrins in the treatment of a mouse model of Niemann-pick C disease","volume":"70","author":"Camargo","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0160","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1203\/PDR.0b013e3181ee4dd2","article-title":"Weekly cyclodextrin administration normalizes cholesterol metabolism in nearly every organ of the Niemann-pick type C1 mouse and markedly prolongs life","volume":"68","author":"Ramirez","year":"2010","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0165","doi-asserted-by":"crossref","first-page":"276ra26","DOI":"10.1126\/scitranslmed.3010101","article-title":"Intracisternal cyclodextrin prevents cerebellar dysfunction and Purkinje cell death in feline Niemann-Pick type C1 disease","volume":"7","author":"Vite","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0170","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0022-2275(20)38456-X","article-title":"Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans","volume":"29","author":"Kempen","year":"1988","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0175","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ajmg.b.30969","article-title":"Linear clinical progression, independent of age of onset, in Niemann-pick disease, type C","volume":"153B","author":"Yanjanin","year":"2010","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0180","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1172\/JCI72835","article-title":"Relative acidic compartment volume as a lysosomal storage disorder\u2013associated biomarker","volume":"124","author":"Te Vruchte","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0185","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/8756479315621287","article-title":"Ultrasound accuracy of liver length measurement with cadaveric specimens","volume":"32","author":"Riestra-Candelaria","year":"2016","journal-title":"J. Diagn. Med. Sonogr."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0190","series-title":"Diagnostic radiology","author":"OHSU","year":"2023"},{"key":"10.1016\/j.ymgmr.2023.100988_bb0195","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2214.1987.tb00554.x","article-title":"A 2-year follow-up study of children with motor coordination problems identified at school entry age","volume":"13","author":"Roussounis","year":"1987","journal-title":"Child Care Health Dev."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0200","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1179\/jmt.2009.17.3.163","article-title":"Global rating of change scales: a review of strengths and weaknesses and considerations for design","volume":"17","author":"Kamper","year":"2009","journal-title":"J. Man. Manip. Ther."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0205","doi-asserted-by":"crossref","DOI":"10.1007\/s11136-022-03180-5","article-title":"Comparing patient global impression of severity and patient global impression of change to evaluate test\u2013retest reliability of depression, non-small cell lung cancer, and asthma measures","author":"Eremenco","year":"2022","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0210","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1177\/0192623312441405","article-title":"Long-term parenteral administration of 2-hydroxypropyl-\u03b2-cyclodextrin causes bone loss","volume":"40","author":"Kantner","year":"2012","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0215","first-page":"45","article-title":"Miglustat treatment may reduce cerebrospinal fluid levels of the axonal degeneration marker tau in Niemann-pick type C","volume":"3","author":"Mattsson","year":"2012","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0220","series-title":"Meeting Report for: Niemann-Pick Type C Patient and Caregiver Voices: Externally-Led, Patient-Focused Drug Development Meeting with the U.S. Food and Drug Administration (FDA)","year":"2019"},{"issue":"4","key":"10.1016\/j.ymgmr.2023.100988_bb0225","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ymgme.2022.10.004","volume":"137","author":"Hastings","year":"2022","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0230","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s13023-019-1207-1","article-title":"Expanded access with intravenous hydroxypropyl-beta-cyclodextrin to treat children and young adults with Niemann-Pick disease type C1: a case report analysis","volume":"14","author":"Hastings","year":"2019","journal-title":"Orphanet. J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0235","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ymgme.2015.07.001","article-title":"Intrathecal 2-hydroxypropyl-beta-cyclodextrin in a single patient with Niemann-Pick C1","volume":"116","author":"Maarup","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0240","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/S0140-6736(17)31465-4","article-title":"Intrathecal 2-hydroxypropyl-beta-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial","volume":"390","author":"Ory","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ymgmr.2023.100988_bb0245","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s12640-020-00252-7","article-title":"2-Hydroxypropyl-\u03b2-cyclodextrin ototoxicity in adult rats: rapid onset and massive destruction of both inner and outer hair cells above a critical dose","volume":"38","author":"Liu","year":"2020","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0250","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/jimd.12428","article-title":"Efficacy and safety of arimoclomol in Niemann-Pick disease type C: results from a double-blind, randomised, placebo-controlled, multinational phase 2\/3 trial of a novel treatment","volume":"44","author":"Mengel","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0255","doi-asserted-by":"crossref","first-page":"30178","DOI":"10.1074\/jbc.272.48.30178","article-title":"Importance of a novel oxidative mechanism for elimination of brain cholesterol. Turnover of cholesterol and 24(S)-hydroxycholesterol in rat brain as measured with 18O2 techniques in vivo and in vitro","volume":"272","author":"Bj\u00f6rkhem","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0260","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13195-020-00648-9","article-title":"CSF total tau\/\u03b1-synuclein ratio improved the diagnostic performance for Alzheimer's disease as an indicator of tau phosphorylation","volume":"12","author":"Shim","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0265","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1176\/appi.ajp.159.3.474","article-title":"Combined analysis of CSF tau levels and [(123)I]iodoamphetamine SPECT in mild cognitive impairment: implications for a novel predictor of Alzheimer\u2019s disease","volume":"159","author":"Okamura","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ymgmr.2023.100988_bb0270","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13023-015-0274-1","article-title":"A novel, highly sensitive and specific biomarker for Niemann-pick type C1 disease","volume":"10","author":"Giese","year":"2015","journal-title":"Orphanet. J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0275","article-title":"Plasma lyso-sphingomyelin levels are positively associated with clinical severity in acid sphingomyelinase deficiency","volume":"28","author":"Breilyn","year":"2021","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0280","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ymgme.2020.01.007","article-title":"Application of N-palmitoyl-O-phosphocholineserine for diagnosis and assessment of response to treatment in Niemann-pick type C disease","volume":"129","author":"Sidhu","year":"2020","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0285","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0720-048X(01)00466-1","article-title":"Sonographic measurements of the liver, spleen and kidney dimensions in the healthy term and preterm newborns","volume":"43","author":"Soyupak","year":"2002","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0290","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.2214\/ajr.171.6.9843315","article-title":"Normal liver, spleen, and kidney dimensions in neonates, infants, and children: evaluation with sonography","volume":"171","author":"Konu\u015f","year":"1998","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.ymgmr.2023.100988_bb0295","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1148\/radiol.2311020963","article-title":"Spleen length in childhood with US: normal values based on age, sex, and somatometric parameters","volume":"231","author":"Megremis","year":"2004","journal-title":"Radiology."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426923000344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426923000344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:54:29Z","timestamp":1762001669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426923000344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":59,"alternative-id":["S2214426923000344"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2023.100988","relation":{},"ISSN":["2214-4269"],"issn-type":[{"value":"2214-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term administration of intravenous Trappsol\u00ae Cyclo\u2122 (HP-\u03b2-CD) results in clinical benefits and stabilization or slowing of disease progression in patients with Niemann-Pick disease type C1: Results of an international 48-week Phase I\/II trial","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2023.100988","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100988"}}